Home > Boards > US Listed > Biotechs > Stemline Therapeutics (STML)

Yes. Just watch ;)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
LPC47 Member Profile
 
Followed By 0
Posts 26
Boards Moderated 0
Alias Born 04/03/13
160x600 placeholder
Stemline Therapeutics Announces Three ELZONRIS (tagraxofusp) Clinical Presentations at EHA Congress June 13-15 GlobeNewswire Inc. - 6/13/2019 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/11/2019 5:03:08 PM
Notice of Exempt Solicitation. Definitive Material. (px14a6g) Edgar (US Regulatory) - 6/11/2019 3:44:59 PM
Stemline Therapeutics Announces ASCO Presentation of ELZONRIS Phase 2 Clinical Data in CMML and MF; Provides Next Steps for C... GlobeNewswire Inc. - 6/3/2019 7:30:00 AM
Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at Upcoming EHA Annual Congress GlobeNewswire Inc. - 5/20/2019 7:00:00 AM
Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at the Upcoming ASCO Annual Meeting GlobeNewswire Inc. - 5/16/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 4:17:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2019 7:31:17 AM
Stemline Therapeutics Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/10/2019 6:30:00 AM
Stemline Therapeutics to Host Conference Call on First Quarter 2019 Financial Results on May 10, 2019 GlobeNewswire Inc. - 5/8/2019 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/2/2019 6:03:32 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 5:22:44 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 5:20:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2019 8:33:42 AM
Stemline Therapeutics Announces New England Journal of Medicine Publication of ELZONRIS (tagraxofusp) Pivotal Study Results GlobeNewswire Inc. - 4/25/2019 7:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/19/2019 5:02:16 PM
Stemline Therapeutics to Participate in Panel on Myeloid Tumors at the 31st Annual ROTH Conference GlobeNewswire Inc. - 3/18/2019 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/15/2019 5:10:18 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/15/2019 4:21:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/15/2019 4:11:11 PM
Stemline Therapeutics Reports Fourth Quarter 2018 Financial Results GlobeNewswire Inc. - 3/15/2019 4:01:00 PM
Stemline Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire Inc. - 3/6/2019 7:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/22/2019 4:40:14 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2019 10:19:52 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 7:51:04 AM
LPC47   Monday, 12/02/13 06:39:57 PM
Re: None
Post # of 48 
Yes. Just watch ;)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist